Guoheng Zhong

Guoheng Zhong

Auto-generated profile, based on publicly available information

Guoheng Zhong

State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Department of Cardiology, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China (D.H., Y.L., H.H., G.X., J.L., L.H., M.X., X.L., L.W., S.S., X.D., G.Z., Q.Z.).

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in Science Advances
Verified
Journal Article
Open access
GZGuoheng Zhong
Guoheng Zhong
SSShuwen Su
Shuwen Su
JLJuncong Li
Juncong Li
HZHengli Zhao
Hengli Zhao
DHDongtu Hu
Dongtu Hu
Qingchun ZengQingchun Zeng
Qingchun Zeng
Hemodynamic overload and dysregulation of cellular metabolism are involved in development of calcific aortic valve disease (CAVD). However, how mechanical stress relates to metabolic changes in CAVD remains unclear. Here, we show that Piezo1, a mechanosensitive ion channel, regulated glutaminase 1 (GLS1)–mediated glutaminolysis to promote osteogenic differentiation of valve interstitial cells (VICs). In vivo, two models of aortic valve stenosis were constructed by ascending aortic constriction (AAC) and direct wire injury (DWI). Inhibition of Piezo1 and GLS1 in these models respectively mitigated aortic valve lesion. In vitro, Piezo1 activation induced by Yoda1 and oscillatory stress triggered osteogenic responses in VICs, which were prevented by Piezo1 inhibition or knockdown. Mechanistically, Piezo1 activation promoted calcium-dependent Yes-associated protein (YAP) activation. YAP modulated GLS1-mediated glutaminolysis, which enhanced osteogenic differentiation through histone acetylation of runt-related transcription factor 2 (RUNX2) promoters. Together, our work provided a cross-talk between mechanotransduction and metabolism in the context of CAVD.

30 January 2026 in Circulation Research
Verified
Journal Article
Closed access
DHDongtu Hu
Dongtu Hu
YLYingwen Lin
Yingwen Lin
HHHailun Huang
Hailun Huang
GXGaopeng Xian
Gaopeng Xian
YCYubing Chen
Yubing Chen
Qingchun ZengQingchun Zeng
Qingchun Zeng
BACKGROUND: Circular RNAs are implicated in various physiopathologic activities and play a crucial role in calcific aortic valve disease (CAVD) progression. However, the role of coding circular RNAs in CAVD remains unclear. In this study, we aimed to characterize coding circular RNAs and explore their functions in CAVD. METHODS: Using a systematic approach from transcriptome sequencing to experimental validation, we identified circZBTB44, confirmed its translation into ZBTB44-342aa, and investigated the function and mechanism of this peptide in CAVD using both cellular and animal models. RESULTS: We found that circZBTB44 promotes the translation of ZBTB44-342aa through N6-methyladenosine modifications. Functionally, ZBTB44-342aa binds to IGF2BP3 (insulin-like growth factor 2 mRNA-binding protein 3), which inhibits mitochondrial damage and mtDNA release into the cytoplasm, thereby suppressing the activation of the cGAS-STING (stimulator of interferon genes) pathway and alleviating the osteogenic differentiation of human aortic valve interstitial cells. Consistent with this, both circZBTB44 overexpression and STING deprivation alleviated aortic valve lesions in vivo, while in vitro, overexpressing circZBTB44 or adding ZBTB44-342aa recombinant protein inhibited the osteogenic response. Conversely, siRNA-mediated knockdown of circZBTB44 enhanced this response. Furthermore, STING inhibition by H-151 alleviated the osteogenic response, whereas its activation by dimeric amidobenzimidazole exacerbated it. CONCLUSIONS: This study demonstrates that circZBTB44-encoded ZBTB44-342aa alleviates CAVD progression by inhibiting the cGAS-STING signaling pathway, thereby identifying both circZBTB44 and STING as potential therapeutic targets.

7 May 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
HZHengli Zhao
Hengli Zhao
JJJiaxue Jiang
Jiaxue Jiang
GZGuoheng Zhong
Guoheng Zhong
YPYou Peng
You Peng
YWYihong Wen
Yihong Wen
ZSZhixin Shan
Zhixin Shan
Background: Among those with heart failure (HF), women are more likely to develop depression than men. Few studies have focused on the outcomes of female patients with HF with depressive symptoms. Methods and Results: A total of 506 female patients with HF with preserved ejection fraction were included in this secondary analysis from the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) cohort, and 439 female patients with HF with reduced ejection fraction were included from the HF‐ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) cohort. Depressive symptoms were measured using the Patient Health Questionnaire‐9 and Beck Depression Inventory‐II. The depression class was categorized by severity, and the change in clinical depression class was defined as aggravated (1‐grade increase) or improved (1‐grade decrease). The prognostic value of depressive symptoms was determined by using multivariable Cox proportional hazards models. Female patients with improved depressive symptoms had worse depressive status at baseline and lower baseline Kansas City Cardiomyopathy Questionnaire scores. Depression class at the 12‐month visit and depression class change were the dominant prognostic factors for cardiovascular death in female patients with HF with preserved ejection fraction (hazard ratio [HR], 1.43 [95% CI, 1.02–2.01], P =0.036; HR, 1.71 [95% CI, 1.14–2.55], P =0.009). Among the patients with HF with reduced ejection fraction, both the depression class at baseline and depression class change had significant prognostic effects on cardiovascular death (HR, 3.30 [95% CI, 1.70–6.39], P <0.001; HR, 2.21 [95% CI, 1.28–3.80], P =0.004). However, the prognostic value of depressive assessments for hospitalization in patients with HF is unclear. Conclusions: In female patients with HF with reduced ejection fraction, the depression class at baseline was most strongly associated with cardiovascular death, whereas in female patients with HF with preserved ejection fraction, the change in depression class exhibited a more significant prognostic trend.